Your browser doesn't support javascript.
loading
De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation.
Bui, A N; Hirner, J; Singer, S B; Eberly-Puleo, A; Larocca, C; Lian, C G; LeBoeuf, N R.
Afiliación
  • Bui AN; Harvard Medical School, Boston, MA, USA.
  • Hirner J; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
  • Singer SB; Harvard Medical School, Boston, MA, USA.
  • Eberly-Puleo A; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Larocca C; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
  • Lian CG; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
Clin Exp Dermatol ; 46(2): 328-337, 2021 Mar.
Article en En | MEDLINE | ID: mdl-32939795

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / Exantema / Inhibidores de Puntos de Control Inmunológico / Metástasis de la Neoplasia Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / Exantema / Inhibidores de Puntos de Control Inmunológico / Metástasis de la Neoplasia Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article